News
NewsPharma Pulse
Academy
Publications
Partner Perspectives
More
Webcasts
Resources
Conferences
Conference CoverageConference Listing
Events
Videos
VideosPeer Exchange
Podcasts
Editorial PodcastsSponsored Podcasts

Subscribe

  • News
  • Academy
  • Publications
  • Partner Perspectives
  • Webcasts
  • Resources
  • Conferences
  • Events
  • Videos
  • Podcasts
  • Subscribe
  • Brand & Product Security
    • Legal & Regulatory
    • Trade & Brand Protection
    • Traceability
  • Business and Finance
  • Cold Chain
    • Containers & Shippers
    • Software
    • Devices
  • Commercial Channels
  • Data & Technology
    • Real World Data
    • Digitalization
    • Artificial Intelligence
  • Logistics & Transportation
    • Manufacturing & Packaging
    • 3PL
    • Supply Chain
  • Market Access
    • Pricing
    • Commercialization
    • Trade & Channel
  • Opinion
  • Patient Support
    • Patient Assistance Programs
    • HUB Services
    • Adherence
Spotlight -
Digital Editions|
Security|
Asembia AXS25 Summit
Advertisement

Tony Lanzone, Campbell Alliance

Advertisement

Articles by Tony Lanzone, Campbell Alliance

Developing a comprehensive pre-launch trade and distribution strategy for specialty products

ByTony Lanzone, Campbell Alliance
February 18th 2009

Establishing appropriate trade channels is crucial to the launch success of specialty pharmaceuticals

Advertisement

Latest Updated Articles

  • Developing a comprehensive pre-launch trade and distribution strategy for specialty products
    Developing a comprehensive pre-launch trade and distribution strategy for specialty products

    Published: February 18th 2009 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Commerce

1

Pharma Pulse: Telehealth Medication Abortion Requests Surge, FDA Expedites Tzield Review, and New Biopharma Air Network Launches

2

Frontier Scientific Solutions, ATSG Partner to Launch Air Network for Temperature-Controlled Pharmaceuticals

3

Pharma Pulse: Amazon Enters Weight-Loss Drug Market, Merck Expands US Manufacturing, and FDA Approves Tezspire for Chronic Sinusitis

4

The Hidden Costs of Specialty Drug Access and Patient Loneliness

5

HDA 2025 Traceability Seminar: DSCSA Compliance Ushers in a More Secure and Transparent Pharma Supply Chain

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us